Trials / Recruiting
RecruitingNCT04981821
A Randomized Trial of a Mobile Health Exercise Intervention for Older Adults With Myeloid Neoplasms
A Pilot Randomized Trial of a Mobile Health Exercise Intervention for Older Patients With Myeloid Neoplasms
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 170 (estimated)
- Sponsor
- University of Rochester · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase 2 randomized controlled trial (RCT) to assess the preliminary efficacy of the a mobile health exercise intervention (GO-EXCAP) versus a chemotherapy education control in 100 older patients with MN receiving outpatient chemotherapy on physical function and patient-reported outcomes (fatigue, mood, and quality of life). We will also explore the effect of the intervention on TNFα and related cytokine gene promoter methylation and their gene and protein expression.
Detailed description
Up to 98% of older patients with myeloid neoplasms experience physical function decline, fatigue, and mood disturbances. Mobile health exercise interventions are promising strategy to prevent physical function decline and improve fatigue and mood disturbances, but older patients with myeloid neoplasms receiving outpatient chemotherapy are understudied. The proposed study will investigate whether a novel mobile health exercise intervention that is adapted to this population can prevent physical function decline, improve fatigue and mood disturbances, and prevent worsening quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | GO-EXCAP Mobile App | A mobile app delivery platform to deliver an exercise program \[Exercise for Cancer Patients (EXCAP©®)\]. EXCAP©®) is a progressive walking and resistance exercise program |
| BEHAVIORAL | Behavioral Placebo Control | Participants will meet with an oncology nurse (for approximately 60 min) to review the NCI booklet Chemotherapy and You: Support for People With Cancer, which includes facts about chemotherapy and its side effects. They will be provided with NCI online resources to review at home. |
Timeline
- Start date
- 2022-01-03
- Primary completion
- 2026-06-30
- Completion
- 2026-12-31
- First posted
- 2021-07-29
- Last updated
- 2026-04-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04981821. Inclusion in this directory is not an endorsement.